Key informationObjectiveThe initial objective was to assess if the study product had an impact on microbiome...
![[CASE STUDY] Microbiome Neutral](https://www.biofortis.fr/wp-content/uploads/2023/05/Microbiome-neutral-940x675.png)
Key informationObjectiveThe initial objective was to assess if the study product had an impact on microbiome...
Key informationMain study endpoints- Reduction in the incidence rate of infectious diarrhea - Modulation of intestinal...
There is growing evidence that the gut and the brain are linked. First observation: mental illnesses are commonly...
For more information, don't hesitate to contact us :
New EasyBioM® V3 launch offer*!Try the new version and get 30% off your shotgun analyses !*EasyBioM® is the Biofortis application for customized visualization of metagenomic data. This offer is...
Lancement de l’Alliance Promotion MicrobioteLe 29 mars 2021 – L’Alliance Promotion Microbiote est lancée : fruit de l’union d’une quinzaine d’acteurs publics et privés engagés (instituts de...
31 mars 2021 de 9h30 à 12h : Atelier produits de santé et microbiomeA l’occasion du Printemps de la Recherche Clinique de l’AFCROs, Biofortis vous propose un atelier autour du thème “Le microbiome,...
Morgane Pierre, Sophie Le Fresne-Languille & Thomas Carton, Biofortis The nasal cavity is a highly complex air-filled space with several distinct zones. As the first part of therespiratory...
5th Microbiome Movement Drug Development Europe 2021 28th-29th of January Come and e-meet us at the 5th Microbiome Movement – Drug Development Europe 2021 Congress to learn more about microbiome...